{
    "id": 15074,
    "fullName": "IL7R act mut",
    "impact": "unknown",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "IL7R act mut indicates that this variant results in a gain of function in the Il7r protein. However, the specific amino acid change has not been identified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 3575,
        "geneSymbol": "IL7R",
        "terms": [
            "IL7R",
            "CD127",
            "CDW127",
            "IL-7R-alpha",
            "IL7RA",
            "ILRA"
        ]
    },
    "variant": "act mut",
    "createDate": "12/09/2015",
    "updateDate": "10/08/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 3736,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Jakafi (ruxolitinib) induced cell death in primary T-cell acute leukemia cells harboring activating mutations in IL7R in culture (PMID: 21892159).",
            "molecularProfile": {
                "id": 15330,
                "profileName": "IL7R act mut"
            },
            "therapy": {
                "id": 907,
                "therapyName": "Ruxolitinib",
                "synonyms": null
            },
            "indication": {
                "id": 9952,
                "name": "acute lymphoblastic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4067,
                    "pubMedId": 21892159,
                    "title": "Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21892159"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 15330,
            "profileName": "IL7R act mut",
            "profileTreatmentApproaches": [
                {
                    "id": 7203,
                    "name": "JAK Inhibitor (Pan) - ATP competitive",
                    "profileName": "IL7R act mut"
                },
                {
                    "id": 7202,
                    "name": "JAK1 Inhibitor - ATP competitive",
                    "profileName": "IL7R act mut"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}